UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035187
Receipt number R000039883
Scientific Title Randomized controlled trial to examine the ability of colorectal lesion detection using 3D monitor system
Date of disclosure of the study information 2018/12/10
Last modified on 2018/12/09 14:13:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial to examine the ability of colorectal lesion detection using 3D monitor system

Acronym

Examination for the ability for colorectal lesion detection using 3D monitor system

Scientific Title

Randomized controlled trial to examine the ability of colorectal lesion detection using 3D monitor system

Scientific Title:Acronym

Examination for the ability for colorectal lesion detection using 3D monitor system

Region

Japan


Condition

Condition

colon polyp

Classification by specialty

Hepato-biliary-pancreatic medicine Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim was to evaluate whether adenoma detection rate (ADR), which is considered to be the most important quality indicator of colonoscopy, is improved by using 3D monitor.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

adenoma detection rate

Key secondary outcomes

polyp detection rate
polyp per colonoscopy
colonoscope insertion time


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

observation by white light

Interventions/Control_2

observation by 3D colonoscopy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Screening including fecal occult blood test positive
2) Surveillance after endoscopic resection of colon neoplastic lesion
3) Scrutiny of abdominal cases

Key exclusion criteria

1) Patients with inflammatory bowel disease (ulcerative colitis, Crohn's disease, etc.)
2) Patients with familial adenomatous polyposis
3) Patients with history of colon resection
4) Patients who are strongly suspected of having tumor before examination (such as when suspected by other imaging tests or when lesions have not been excised at previous colonoscopy)
5) Patients who have difficulty in lesion biopsy (such as chronic blood diseases)
6) Patients who can not discontinue anticoagulant or antiplatelet drug according to endoscopic clinical practice guidelines

Target sample size

362


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Arai

Organization

Chiba University Hospital

Division name

Department of Gastroenterology

Zip code


Address

Chiba

TEL

0432262086

Email

araim-cib@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Akizue

Organization

Chiba University Hospital

Division name

Department of Gastroenterology

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba

TEL

0432262086

Homepage URL


Email

n.akizue@gmail.com


Sponsor or person

Institute

Department of Gastroenterology, Chiba University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology, Chiba University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学病院(千葉県)


Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 04 Month 10 Day

Date of IRB


Anticipated trial start date

2018 Year 05 Month 10 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 12 Month 09 Day

Last modified on

2018 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039883


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name